Cardiff Oncology Inc (CRDF)
3.325
-0.14
(-3.90%)
USD |
NASDAQ |
May 07, 16:00
3.325
0.00 (0.00%)
After-Hours: 19:05
Cardiff Oncology Price to Book Value: 2.442 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.541 |
| May 03, 2024 | 2.585 |
| May 02, 2024 | 3.290 |
| May 01, 2024 | 3.107 |
| April 30, 2024 | 3.202 |
| April 29, 2024 | 3.276 |
| April 26, 2024 | 2.989 |
| April 25, 2024 | 2.930 |
| April 24, 2024 | 3.069 |
| April 23, 2024 | 3.062 |
| April 22, 2024 | 3.201 |
| April 19, 2024 | 3.194 |
| April 18, 2024 | 3.209 |
| April 17, 2024 | 3.304 |
| April 16, 2024 | 3.370 |
| April 15, 2024 | 3.877 |
| April 12, 2024 | 4.119 |
| April 11, 2024 | 4.163 |
| April 10, 2024 | 4.325 |
| April 09, 2024 | 4.156 |
| April 08, 2024 | 4.317 |
| April 05, 2024 | 4.288 |
| April 04, 2024 | 4.163 |
| April 03, 2024 | 3.913 |
| April 02, 2024 | 3.943 |
| Date | Value |
|---|---|
| April 01, 2024 | 4.207 |
| March 31, 2024 | |
| March 28, 2024 | 3.421 |
| March 27, 2024 | 3.684 |
| March 26, 2024 | 3.453 |
| March 25, 2024 | 3.786 |
| March 22, 2024 | 3.748 |
| March 21, 2024 | 3.293 |
| March 20, 2024 | 3.178 |
| March 19, 2024 | 3.120 |
| March 18, 2024 | 3.312 |
| March 15, 2024 | 3.222 |
| March 14, 2024 | 3.459 |
| March 13, 2024 | 3.459 |
| March 12, 2024 | 2.87 |
| March 11, 2024 | 2.588 |
| March 08, 2024 | 2.652 |
| March 07, 2024 | 2.249 |
| March 06, 2024 | 2.492 |
| March 05, 2024 | 2.338 |
| March 04, 2024 | 2.236 |
| March 01, 2024 | 1.864 |
| February 29, 2024 | 1.131 |
| February 28, 2024 | 1.166 |
| February 27, 2024 | 1.140 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3894
Minimum
May 11 2022
26.04
Maximum
Nov 30 2020
2.699
Average
1.459
Median
Price to Book Value Benchmarks
| BioVie Inc | 2.631 |
| Perspective Therapeutics Inc | 14.33 |
| Biolase Inc | -- |
| Tenon Medical Inc | 4.168 |
| Adial Pharmaceuticals Inc | 1.559 |
Price to Book Value Related Metrics
| PS Ratio | 243.53 |
| PEG Ratio | -3.288 |
| Price | 3.325 |
| Earnings Yield | -27.07% |
| Market Cap | 148.71M |
| PEGY Ratio | -3.288 |